Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid

Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the global prevalence of resistance to these drugs and the impact of resistance on treatment outcomes. Mycobacterium tub...

Full description

Bibliographic Details

Published in:	PLOS global public health Vol. 3; no. 10; p. e0002283
Main Authors:	Timm, Juliano, Bateson, Anna, Solanki, Priya, Paleckyte, Ana, Witney, Adam A., Rofael, Sylvia A. D., Fabiane, Stella, Olugbosi, Morounfolu, McHugh, Timothy D., Sun, Eugene
Format:	Journal Article
Language:	English
Published:	San Francisco, CA USA Public Library of Science 18.10.2023 Public Library of Science (PLoS)
Subjects:	Biology and Life Sciences Medicine and Health Sciences
ISSN:	2767-3375, 2767-3375
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!